-
Novo Nordisk acquires Cardior for 1 billion euros to accelerate its layout in the cardiovascular field
On Monday local time, Danish pharmaceutical giant Novo Nordisk announced that it will acquire Cardio Pharmaceuticals for 1.03 billion euros, and the two companies have reached a related acquisition a ...- Ty奇葩罗牛山831
- 2024-3-26
- サポート
- に反対
- 返信
- コレクション
-
AstraZeneca and Sinopharm Group reach nearly $2 billion cardiovascular drug authorization agreement
AstraZeneca and Shiyao Group Limited have reached an exclusive licensing agreement to advance the development of a preclinical innovative small molecule lipoprotein (a) (Lp (a)) inhibitor. According ...